Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study

Sherif M Gamal, Nermeen Fouad, Nora Yosry, Wael Badr, Nesreen Sobhy

DOI: 10.46497/ArchRheumatol.2022.8888

Issue: Volume 37 - Issue 2 - June 2022
3293 2681

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252

Issue: Volume 37 - Issue 2 - June 2022
3261 3288

Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic

Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam

DOI: 10.46497/ArchRheumatol.2022.8996

Issue: Volume 37 - Issue 2 - June 2022
2890 2650

Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China

Ke Zhang, Chunmei He, Qiaoting Deng, Wengen Li, Zhixiong Zhong, Jingyuan Hou

DOI: 10.46497/ArchRheumatol.2022.8870

Issue: Volume 37 - Issue 1 - March 2022
1961 2728

Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus

Yunus Durmaz, İlker İlhanlı, Pınar Durmaz

DOI: 10.46497/ArchRheumatol.2022.9002

Issue: Volume 37 - Issue 3 - September 2022
2509 2575

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study

Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee

DOI: 10.46497/ArchRheumatol.2022.9140

Issue: Volume 37 - Issue 3 - September 2022
2356 1753

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi

DOI: 10.46497/ArchRheumatol.2022.9217

Issue: Volume 37 - Issue 3 - September 2022
2193 1739

The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus

Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec

DOI: 10.46497/ArchRheumatol.2022.9255

Issue: Volume 37 - Issue 4 - December 2022
2147 2044

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients

Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed

DOI: 10.46497/ArchRheumatol.2022.9307

Issue: Volume 37 - Issue 4 - December 2022
2176 1670

Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus

Yuewu Tang, Yi Luo

DOI: 10.46497/ArchRheumatol.2022.9167

Issue: Volume 37 - Issue 4 - December 2022
2036 1810

Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?

Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin

DOI: 10.46497/ArchRheumatol.2022.9366

Issue: Volume 37 - Issue 4 - December 2022
8311 2651

Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up

Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine

DOI: 10.46497/ArchRheumatol.2023.9448

Issue: Volume 38 - Issue 1 - March 2023
2040 1735

Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity

Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh

DOI: 10.46497/ArchRheumatol.2023.9549

Issue: Volume 38 - Issue 3 - September 2023
2182 1524

Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies

Sherif Gamal, Hanaa Rady, Nesreen Sobhy, Ibrahem Siam, Ahmed Soliman, Fatema Elgengehy

DOI: 10.46497/ArchRheumatol.2023.9860

Issue: Volume 38 - Issue 3 - September 2023
2688 1383

The effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on cytokines and their related molecules: An ex vivo study on patients with systemic lupus erythematosus

Atefeh Alaei, Mahmoud Mahmoudi, Maryam Sahebari, Zohreh Vahidi, Nafiseh Tabasi, Maryam Rastin

DOI: 10.46497/ArchRheumatol.2023.9941

Issue: Volume 38 - Issue 4 - December 2023
2172 1502

Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis

Maka Gegenava, Zviad Kirtava, William KF Kong, Tea Gegenava

DOI: 10.46497/ArchRheumatol.2024.10131

Issue: Volume 39 - Issue 1 - March 2024
1942 1255

Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus

Lingyan He, Mingming Yan, Rui Wen, Jiali Li

DOI: 10.46497/ArchRheumatol.2024.9977

Issue: Volume 39 - Issue 2 - June 2024
1818 1162

Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome

Nevsun Pihtili Taş, Rabia Aydogan Baykara, Ayhan Kamanli, Ali Gürbüz, Erkan Cure, Medine Cumhur Cüre, Mehmet Erdem, Tugce Tasar Yildirim

DOI: 10.46497/ArchRheumatol.2024.10462

Issue: Volume 39 - Issue 3 - September 2024
1370 1001

Evaluation of adipokines, oxidative stress, and inflammatory markers in gout patients

Fatma Ozer, Fatih Baygutalp, Muhammet Celik, Nurcan Kılıc Baygutalp

DOI: 10.46497/ArchRheumatol.2025.11001

Issue: Volume 40 - Issue 1 - March 2025
1362 540